Pacira Biosciences Inc (PCRX)
23.39
-0.09%
Pacira Biosciences Inc (PCRX) is currently trading at $23.39. This represents a loss of 0.09% from the previous session. With a market capitalization of $0.96B, PCRX is a key component of the Health Care sector. Investors looking to trade PCRX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Claim Your $300 Cash Bonus →
T&Cs Apply. Trade PCRX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Pacira Biosciences Inc (PCRX) shows a bearish trend. Analysts are watching the 23.68 level closely.
Fundamentals
Mkt Cap0.96B
P/E Ratio0.0000
Volume337,976
60-Day Technical Chart
Advanced Charting
Need more indicators for PCRX? Use the world's #1 platform.
Open PCRX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $23
| Metric |
PCRX -0.09% |
BMNR +10.60% |
TTD +0.88% |
HL -1.40% |
|---|---|---|---|---|
| Price | $23.39 | $21.51 | $25.16 | $23.31 |
| Mkt Cap | $0.96B | $9.80B | $12.33B | $15.63B |
| - | View → | View → | View → |
Latest Headlines
Pacira BioSciences, Inc. (PCRX) Stock Analysis: A Healthcare Innovator with 28.58% Potential Upside
DirectorsTalk Interviews • Feb 25, 2026
DOMA Perpetual Sends Letter Calling for the Board of Directors of Pacira BioSciences, Inc. to Immediately Explore a Sale of the Business
PR Newswire • Nov 10, 2025
Pacira hands new hires $21.02 stock options and RSUs
Stock Titan • Feb 9, 2026
PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates
Zacks Investment Research • Jan 12, 2026
PCRX Stock Down 10% as Preliminary Q4 Revenues Miss Estimates
TradingView • Jan 12, 2026
● Gemini Agentic AI Analyst Insight for PCRX
Market Education
- The Basics of the Stock Market for Beginners Aug 25, 2023
- Want to be a Wall street billionaire, take their investing advice Jul 19, 2023
- Making Sense of Money: How Interest Rates, Bonds, and Stocks Affect Your Wallet Feb 21, 2024
External Research